特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
236787

ボツリヌス毒素の世界市場

Botulinum Toxin

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 146 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.14円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

ボツリヌス毒素の世界市場
出版日: 2020年07月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 146 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のボツリヌス毒素市場について調査し、市場の概要と成長動向、製品概要、および市場に参入する企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 業界概要
    • ボツリヌス毒素:美容と治療への用途拡大が成長を牽引
    • 治療用ボツリヌス毒素用途
    • 線四国が独占
    • 途上国が将来の成長を牽引
    • 医療費高等が治療におけるボツリヌス毒素の需要を促進
    • 美容におけるボツリヌス毒素:有望な用途市場
    • 美容用ボツリヌス毒素市場を牽引する因子
    • 筋骨格適応数の増加
    • 製薬会社は熱心にボツリヌス毒素市場に注目している
  • 競合環境
    • 激しい競争が市場を特徴づける
    • Allerganが世界のボツリヌス毒素市場をリード
    • ボツリヌス毒素製品
    • ボトックス:主要ブランド
    • バイオシミラー
    • 認可済み製品の差別化不足
    • 主な神経毒素の比較
    • 主なボツリヌス毒素製品のレビュー ほか
  • 市場動向と課題
    • 非侵襲性美容治療の需要増加
    • フェイシャル注射剤市場における好ましいソリューション
    • ボトックスの人気
    • 寿命の伸長と可処分所得の増加 ほか
  • 製品概要
    • 治療できる毒素
    • 構造・作用機序
    • 弱点
    • 分類
    • 手技
    • 美容への応用
    • 治療への応用
    • 副作用
  • 製品導入/認可
  • 近年の業界活動
  • 主要企業
    • Allergan Plc
    • Daewoong Pharmaceutical Co., Ltd.
    • HUGEL Pharma
    • Ipsen Group
    • Medy-Tox Inc.
    • Merz Pharma GmbH & Co. KGaA
    • Metabiologics, Inc.
    • Revance Therapeutics, Inc.
    • US WorldMed
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
目次
Product Code: MCP-1833

Global Botulinum Toxin Market to Reach $7.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Botulinum Toxin estimated at US$4.7 Billion in the year 2020, is projected to reach a revised size of US$7.4 Billion by 2027, growing at aCAGR of 6.6% over the period 2020-2027. Therapeutics, one of the segments analyzed in the report, is projected to record 6.8% CAGR and reach US$4.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Aesthetics segment is readjusted to a revised 6.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 6.2% CAGR

The Botulinum Toxin market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing a CAGR of 6.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 5.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.We bring years of research experience to this 19th edition of our report. The 146-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Allergan Plc
  • Daewoong Pharmaceutical Co. Ltd.
  • Ipsen Group
  • Medy-Tox Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Metabiologics Inc.
  • Revance Therapeutics Inc.
  • US WorldMeds

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of Covid-19 and a Looming Global Recession
  • Global Competitor Market Shares
  • Botulinum Toxin Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
  • Botulinum Toxin: Expanding Cosmetic & Therapeutic Applications to Propel Growth
  • Recent Market Activity
  • Therapeutic BTX Applications Lead, Cosmetic BTX Gradually Gaining Momentum
  • Developed Regions Dominate Botulinum Toxin Market
  • Developing Markets to Drive Future Growth
  • Increase in Healthcare Spending Stirs Demand for BTX in Therapeutic Applications
  • Cosmetic BTX - A Promising Application Market
  • Factors Propelling the Cosmetic BT Market - In a Nut Shell
  • Rise in the Number of Musculoskeletal Indications - Potential for Growth
  • Pharma Companies Keenly Eye Lucrative BT Market

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Rising Demand for Non-Invasive Cosmetic Treatments Bodes Well for BTX Market
  • Botulinum Toxin - The Preferred Solution in Facial Injectables Market
  • Botox Gains Popularity among Millennials
  • Longer Life Expectancy and Rising Disposable Incomes Propel Sales of Cosmetic BTX
  • BTX - The Wonder Drug for Increasing Number of Non-Cosmetic Uses
  • BoNT/X - The New Toxin with Potential Use in New Therapeutic Areas
  • Topical Botulinum Toxin: Needle-Free Administration Imparts an Edge over Injected Variants
  • Unmet Medical Needs Encourage Off-Label Use: A Cause for Concern or Jubilation?
  • Urgent Need for Physician Education about Off-Label Usage
  • Campaigns Boost Patient Awareness
  • Digital Revolution to Impact Consumer Choices
  • Financing of Non-Reimbursed Healthcare: Need of the Hour
  • Combination Therapies: A Double Whammy Success
  • Botulinum Toxin - Potential Applications in Treatment of Dental Diseases
  • Short-lived Aesthetic Effects: A Strong Business Case for Revision Treatments
  • Novel Injection Systems for Highly Precise Dosage of Botulinum Toxin
  • Undesirable Side Effects: A Challenge to Reckon With
  • Immunogenicity Undermines Patient Compliance
  • Reduction of Protein Load in BTX Products - The Probable Answer for Immunogenicity
  • Antigenicity: A Problematic Issue in Drug Development
  • Stringent Regulations Delay Market Approvals & Put Reimbursements in Limbo
  • Study Offers Support for Possible Remote Effects with Botulinum Toxin
  • Higher Product Costs to Challenge Market Growth
  • Consumer Skepticism: The Biggest Challenge to Beat
  • Animal Cruelty - A Part & Parcel of Botox Testing
  • Botulinum Toxins - A Wonder Drug or Bio-terror Threat?
  • Fears of Terrorism & Biological Warfare Thwart International Trade

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Botulinum Toxin Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Botulinum Toxin Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Botulinum Toxin Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Therapeutics (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
  • TABLE 5: Therapeutics (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 6: Therapeutics (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Aesthetics (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027
  • TABLE 8: Aesthetics (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
  • TABLE 9: Aesthetics (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
  • TABLE 10: Hospitals & Clinics (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 11: Hospitals & Clinics (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 12: Hospitals & Clinics (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Specialty & Dermatology Clinics (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027
  • TABLE 14: Specialty & Dermatology Clinics (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 15: Specialty & Dermatology Clinics (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Other End-Uses (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 17: Other End-Uses (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 18: Other End-Uses (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Botulinum Toxin Market Share (in %) by Company: 2018 & 2025
    • Market Analytics
    • TABLE 19: United States Botulinum Toxin Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
    • TABLE 20: Botulinum Toxin Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019
    • TABLE 21: Botulinum Toxin Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
    • TABLE 22: United States Botulinum Toxin Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
    • TABLE 23: Botulinum Toxin Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019
    • TABLE 24: Botulinum Toxin Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 25: Canadian Botulinum Toxin Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
    • TABLE 26: Botulinum Toxin Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
    • TABLE 27: Canadian Botulinum Toxin Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 28: Canadian Botulinum Toxin Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 29: Botulinum Toxin Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 30: Canadian Botulinum Toxin Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • JAPAN
    • TABLE 31: Japanese Demand Estimates and Forecasts for Botulinum Toxin in US$ Million by Application: 2020 to 2027
    • TABLE 32: Japanese Botulinum Toxin Market in US$ Million by Application: 2012-2019
    • TABLE 33: Botulinum Toxin Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
    • TABLE 34: Japanese Demand Estimates and Forecasts for Botulinum Toxin in US$ Million by End-Use: 2020 to 2027
    • TABLE 35: Japanese Botulinum Toxin Market in US$ Million by End-Use: 2012-2019
    • TABLE 36: Botulinum Toxin Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 37: Chinese Demand for Botulinum Toxin in US$ Million by Application: 2020 to 2027
    • TABLE 38: Botulinum Toxin Market Review in China in US$ Million by Application: 2012-2019
    • TABLE 39: Chinese Botulinum Toxin Market Share Breakdown by Application: 2012 VS 2020 VS 2027
    • TABLE 40: Chinese Demand for Botulinum Toxin in US$ Million by End-Use: 2020 to 2027
    • TABLE 41: Botulinum Toxin Market Review in China in US$ Million by End-Use: 2012-2019
    • TABLE 42: Chinese Botulinum Toxin Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Botulinum Toxin Market: Competitor Market Share Scenario (in %) for 2018 & 2025
    • Market Analytics
    • TABLE 43: European Botulinum Toxin Market Demand Scenario in US$ Million by Region/Country: 2020-2027
    • TABLE 44: Botulinum Toxin Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 45: European Botulinum Toxin Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 46: European Botulinum Toxin Addressable Market Opportunity in US$ Million by Application: 2020-2027
    • TABLE 47: Botulinum Toxin Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
    • TABLE 48: European Botulinum Toxin Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 49: European Botulinum Toxin Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 50: Botulinum Toxin Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 51: European Botulinum Toxin Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 52: Botulinum Toxin Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
    • TABLE 53: French Botulinum Toxin Historic Market Review in US$ Million by Application: 2012-2019
    • TABLE 54: French Botulinum Toxin Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
    • TABLE 55: Botulinum Toxin Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027
    • TABLE 56: French Botulinum Toxin Historic Market Review in US$ Million by End-Use: 2012-2019
    • TABLE 57: French Botulinum Toxin Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • GERMANY
    • TABLE 58: Botulinum Toxin Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
    • TABLE 59: German Botulinum Toxin Market in Retrospect in US$ Million by Application: 2012-2019
    • TABLE 60: Botulinum Toxin Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
    • TABLE 61: Botulinum Toxin Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
    • TABLE 62: German Botulinum Toxin Market in Retrospect in US$ Million by End-Use: 2012-2019
    • TABLE 63: Botulinum Toxin Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 64: Italian Demand for Botulinum Toxin in US$ Million by Application: 2020 to 2027
    • TABLE 65: Botulinum Toxin Market Review in Italy in US$ Million by Application: 2012-2019
    • TABLE 66: Italian Botulinum Toxin Market Share Breakdown by Application: 2012 VS 2020 VS 2027
    • TABLE 67: Italian Demand for Botulinum Toxin in US$ Million by End-Use: 2020 to 2027
    • TABLE 68: Botulinum Toxin Market Review in Italy in US$ Million by End-Use: 2012-2019
    • TABLE 69: Italian Botulinum Toxin Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 70: United Kingdom Demand Estimates and Forecasts for Botulinum Toxin in US$ Million by Application: 2020 to 2027
    • TABLE 71: United Kingdom Botulinum Toxin Market in US$ Million by Application: 2012-2019
    • TABLE 72: Botulinum Toxin Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
    • TABLE 73: United Kingdom Demand Estimates and Forecasts for Botulinum Toxin in US$ Million by End-Use: 2020 to 2027
    • TABLE 74: United Kingdom Botulinum Toxin Market in US$ Million by End-Use: 2012-2019
    • TABLE 75: Botulinum Toxin Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Botulinum Toxin Addressable Market Opportunity in US$ Million by Application: 2020-2027
    • TABLE 77: Botulinum Toxin Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
    • TABLE 78: Rest of Europe Botulinum Toxin Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 79: Rest of Europe Botulinum Toxin Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
    • TABLE 80: Botulinum Toxin Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
    • TABLE 81: Rest of Europe Botulinum Toxin Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 82: Botulinum Toxin Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
    • TABLE 83: Asia-Pacific Botulinum Toxin Historic Market Review in US$ Million by Application: 2012-2019
    • TABLE 84: Asia-Pacific Botulinum Toxin Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
    • TABLE 85: Botulinum Toxin Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027
    • TABLE 86: Asia-Pacific Botulinum Toxin Historic Market Review in US$ Million by End-Use: 2012-2019
    • TABLE 87: Asia-Pacific Botulinum Toxin Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • REST OF WORLD
    • TABLE 88: Rest of World Botulinum Toxin Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
    • TABLE 89: Botulinum Toxin Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
    • TABLE 90: Rest of World Botulinum Toxin Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 91: Rest of World Botulinum Toxin Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
    • TABLE 92: Botulinum Toxin Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
    • TABLE 93: Rest of World Botulinum Toxin Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 14
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.